Trends in donor infection profiles and residual risks of transfusion‐transmitted human immunodeficiency virus, hepatitis C virus and hepatitis B virus after the implementation of universal mini‐pool nucleic acid testing in Taiwan

Ähnliche Einträge

• The prevalence of hepatitis B virus, human T‐lymphotropic virus and human immunodeficiency virus in patients receiving blood transfusions in South Africa
  von: Reynier J. Willemse, et al.
  Veröffentlicht: (2024)
• Risk factors for incident human immunodeficiency virus infection in South African blood donors
  von: Avril Swarts, et al.
  Veröffentlicht: (2025)
• Comment on ‘Comparing specificity and seroconversion sensitivity among major blood screening assays for human immunodeficiency virus and viral hepatitis’
  von: Ramune Sepetiene, et al.
  Veröffentlicht: (2026)
• Non‐neutralizing antibody profiles against hepatitis B virus: A comparative study of Japanese‐ and US‐donor‐derived intramuscular human hepatitis B‐specific immunoglobulin preparations
  von: Tatsuki Miyamoto, et al.
  Veröffentlicht: (2024)
• Autoantibodies to ADAMTS13 in human immunodeficiency virus‐associated thrombotic thrombocytopenic purpura
  von: Muriel Meiring, et al.
  Veröffentlicht: (2024)